Featured companies in Company

Aqemia
Aqemia aqemia.com
93

Featured

Drug discovery platform.

  • Latest Funding

    $32 Million · Series A

  • Employees

    51 to 100

  • Investors

    Wendel Growth, Bpifrance, Eurazeo, Elaia

  • Business Model

    B2B

  • Industries

    Biotech

  • Locations

    Paris

  • Contact

    •••••@aqemia.com
    Unlock contact info

Eligo Bioscience
Eligo Bioscience eligo.bio
89

Featured

Gene-editing platform.

  • Latest Funding

    $30 Million · Series B

  • Employees

    11 to 50

  • Investors

    Sanofi Ventures, Khosla Ventures, Bpifrance, Seventure Partners

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Contact

    •••••@eligo.bio
    Unlock contact info

Bioptimus
Bioptimus bioptimus.com
89

Featured

Developer of a universal AI foundation model for biology.

  • Latest Funding

    $35 Million · Seed

  • Employees

    1 to 10

  • Investors

    Frst, Bpifrance, Sofinnova Partners, Cathay Innovation

  • Business Model

    B2B, SAAS

  • Industries

    AI, Biotech

  • Locations

    Paris

  • Contact

    •••••@bioptimus.com
    Unlock contact info

Full list of Biotech startups in France

89

Gene-editing platform.

  • Latest Funding

    $30 Million · Series B

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    11 to 50

  • Investors

    Sanofi Ventures, Khosla Ventures, Bpifrance, Seventure Partners

  • Contact

    •••••@eligo.bio
    Unlock contact info

79

Mnemo Therapeutics specializes in biotechnology and life science.

  • Latest Funding

    $90 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    101 to 250

  • Business Model

    B2B

  • Investors

    Sofinnova Partners

  • Contact

    •••••@mnemo-tx.com
    Unlock contact info

SparingVision
SparingVision sparingvision.com
79

SparingVision is a biotechnology company focused development of genomic medicines for the treatment of blinding inherited retinal diseases.

  • Latest Funding

    $53 Million · Series A

  • Industries

    Health Tech, Biotech, Deep Tech

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Ysios Capital

  • Contact

    •••••@sparingvision.com
    Unlock contact info

Enterome
Enterome enterome.com
75

Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases.

  • Latest Funding

    $3.2 Million · Series F

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma

  • Locations

    Paris

  • Employees

    51 to 100

  • Business Model

    B2B

  • Investors

    The Leukemia & Lymphoma Society’s Therapy Acceleration Program, Omnes Capital, Nestlé Health Science, Seventure Partners

  • Contact

    •••••@enterome.com
    Unlock contact info

PiLi
PiLi pili.bio
68

Petroleum-free pigments.

  • Latest Funding

    $16 Million · Series A

  • Industries

    Climate Tech & Green Tech, Biotech, Energy & Nuclear, Manufacturing

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Bpifrance, Elaia

  • Contact

    •••••@pili.bio
    Unlock contact info

Gradient Denervation Technologies
Gradient Denervation Technologies gradientdenervation.com
68

Medical devices for a transvascular treatment of pulmonary hypertension.

  • Latest Funding

    $15 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    1 to 10

  • Investors

    Sofinnova Partners, Asabys Partners

  • Contact

    •••••@gradientdenervation.com
    Unlock contact info

Corteria Pharmaceuticals
Corteria Pharmaceuticals corteriapharma.com
68

Interceptive therapies for heart failure subpopulations.

  • Latest Funding

    $70 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    1 to 10

  • Investors

    OrbiMed, Omnes Capital, Invivo Capital Partners

  • Contact

    •••••@corteriapharma.com
    Unlock contact info

68

Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.

  • Latest Funding

    $46 Million

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Bioqube Ventures

  • Contact

    •••••@egle-tx.com
    Unlock contact info

Eyevensys
Eyevensys eyevensys.com
68

Eyevensys creates ophthalmic therapeutic bio factories to sustainably treat major eye diseases.

  • Latest Funding

    $12 Million · Series B

  • Industries

    Health Tech, Hardware, Biotech, Manufacturing

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Pureos Bioventures, Karista

  • Contact

    •••••@eyevensys.com
    Unlock contact info

Tissium
Tissium tissium.com
68

Niodegradable sealants and adhesives for wound closure.

  • Latest Funding

    $55 Million · Series D

  • Industries

    Health Tech, Hardware, Biotech, Manufacturing

  • Locations

    Paris

  • Employees

    51 to 100

  • Business Model

    B2B

  • Investors

    Bpifrance, CM-CIC Capital Finance, Sofinnova Partners, Cathay Innovation, Omnes Capital, Credit Mutuel, Karista

  • Contact

    •••••@tissium.com
    Unlock contact info

Astraveus
Astraveus astraveus.com
68

Automated bioprocessing system for the production of cell and gene therapies.

  • Latest Funding

    $18 Million · Seed

  • Industries

    Biotech

  • Locations

    Paris

  • Employees

    11 to 50

  • Investors

    AdBio Partners

  • Contact

    •••••@astraveus.com
    Unlock contact info

ENYO Pharma
ENYO Pharma enyopharma.com
67

Vonafexor drug maker for the treatment of Alport syndrome.

  • Latest Funding

    $43 Million · Series C

  • Industries

    Biotech

  • Locations

    Lyon

  • Employees

    1 to 10

  • Investors

    Bpifrance, OrbiMed, Sofinnova Partners, Morningside Venture Investments, Andera Partners

  • Contact

    •••••@enyopharma.com
    Unlock contact info

PathoQuest
PathoQuest pathoquest.com
64

PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.

  • Latest Funding

    $17 Million · Series B

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Eurazeo, Norgine Ventures, Verve Ventures

  • Contact

    •••••@pathoquest.com
    Unlock contact info

EverImmune
EverImmune everimmune.net
64

Developer of biotherapeutic products to treat cancer.

  • Latest Funding

    $3.7 Million · Debt Financing

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    1 to 10

  • Investors

    Bpifrance

  • Contact

    •••••@everimmune.net
    Unlock contact info

Samabriva
Samabriva samabriva.com
64

Biomanufacturer of complex molecules.

  • Latest Funding

    $4.3 Million · Seed

  • Industries

    Biotech, Manufacturing

  • Locations

    Paris

  • Employees

    1 to 10

  • Investors

    Meusinvest (Noshaq)

  • Contact

    •••••@samabriva.com
    Unlock contact info

HEPHAISTOS-Pharma
HEPHAISTOS-Pharma hephaistos-pharma.fr
64

Immunotherapies developer for cancer patient.

  • Latest Funding

    $2.2 Million · Seed

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    1 to 10

  • Investors

    Fournier-Majoie, Meusinvest (Noshaq), xista science ventures

  • Contact

    •••••@hephaistos-pharma.fr
    Unlock contact info

Step Pharma
Step Pharma step-ph.com
64

Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1).

  • Latest Funding

    $41 Million · Series B

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Bpifrance, Idinvest Partners, AGORANOV, Hadean Ventures

  • Contact

    •••••@step-ph.com
    Unlock contact info

Kiro
Kiro kiro.bio
64

AI-dirven clinical biology.

  • Latest Funding

    $15 Million · Series A

  • Industries

    Biotech

  • Locations

    Paris

  • Employees

    11 to 50

  • Investors

    Sofinnova Partners

  • Contact

    •••••@kiro.bio
    Unlock contact info

Antabio
Antabio antabio.com
62

Developer of MEM-ANT3310, a next generation antibacterial combination.

  • Latest Funding

    $27 Million · Series B

  • Industries

    Health Tech, Biotech

  • Locations

    Toulouse

  • Employees

    11 to 50

  • Investors

    BNP Paribas, EIC Accelerator, Omnes Capital, IXO Private Equity, Turenne Capital, Sham Innovation Santé, Galia Gestion, Nubbo Incubator, WiSEED, AMR Action Fund, RDI SORIDEC Gestion

  • Contact

    •••••@antabio.com
    Unlock contact info

Biomemory
Biomemory biomemory-labs.com
59

Biomemory designs a low-cost, biobased solution for storing large amounts of computer data on long DNA strands.

  • Latest Funding

    $5.2 Million

  • Industries

    Health Tech, Biotech, Data and Analytics, Business Intelligence

  • Locations

    Paris

  • Employees

    1 to 10

  • Investors

    Bpifrance

  • Contact

    •••••@biomemory-labs.com
    Unlock contact info

59

Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.

  • Latest Funding

    $6 Million · Series A

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Fountain Healthcare Partners

  • Contact

    •••••@ermium.com
    Unlock contact info

LinKinVax
LinKinVax linkinvax.com
59

Protein-based vaccines.

  • Latest Funding

    $7.8 Million · Series A

  • Industries

    Biotech

  • Locations

    Paris

  • Employees

    1 to 10

  • Investors

    In-Q-Tel

  • Contact

    •••••@linkinvax.com
    Unlock contact info

nextProtein
nextProtein nextprotein.co
59

nextProtein develops a new large-scale technology that produces a sustainable source of protein.

  • Latest Funding

    $11 Million · Series A

  • Industries

    Climate Tech & Green Tech, Agritech, Foodtech, Biotech, Manufacturing

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Blue Oceans Partners

  • Contact

    •••••@nextprotein.co
    Unlock contact info

Stilla Technologies
Stilla Technologies stillatechnologies.com
59

Stilla Technologies is a Paris-based european biotechnology company.

  • Latest Funding

    $13 Million

  • Industries

    Health Tech, Biotech, Genetics

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Eurazeo

  • Contact

    •••••@stillatechnologies.com
    Unlock contact info

59

Gene therapies for rare diseases.

  • Latest Funding

    $39 Million · Series B

  • Industries

    Health Tech, Biotech, Deep Tech

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Bpifrance, Idinvest Partners, Omnes Capital, Kurma Partners, V-Bio Ventures, Seroba Life Sciences

  • Contact

    •••••@coavetx.com
    Unlock contact info

Qubit Pharmaceuticals
Qubit Pharmaceuticals qubit-pharmaceuticals.com
59

Qubit Pharmaceuticals is an EIT Health Headstart laureate and is incubated at Paris Biotech Santé.

  • Latest Funding

    $17 Million · Seed

  • Industries

    Health Tech, Biotech, Pharma, Manufacturing

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Quantonation, XAnge

  • Contact

    •••••@qubit-pharmaceuticals.com
    Unlock contact info

Nūmi
Nūmi numi.life
59

Breast milk producer from cell-cultured mammary glands.

  • Latest Funding

    $3.2 Million · Pre Seed

  • Industries

    Biotech, FamilyTech & Parenting

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2C

  • Investors

    Heartcore, Kima Ventures, Kost Capital, HCVC

  • Contact

    •••••@numi.life
    Unlock contact info

AbolerIS Pharma
AbolerIS Pharma aboleris-pharma.com
56

AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.

  • Latest Funding

    $29 Million · Series A

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    Nantes

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Caixa Capital Risc, Sound Bioventures

  • Contact

    •••••@aboleris-pharma.com
    Unlock contact info

Amolyt Pharma
Amolyt Pharma amolytpharma.com
56

Peptides for the treatment of rare endocrine and related diseases.

  • Latest Funding

    $140 Million · Series C

  • Industries

    Biotech

  • Locations

    Lyon

  • Employees

    11 to 50

  • Investors

    Sofinnova Partners, Intermediate Capital Group

  • Contact

    •••••@amolytpharma.com
    Unlock contact info

Diabeloop
Diabeloop diabeloop.fr
56

Diabeloop is a medical device company for diabetes and closed-loop system.

  • Latest Funding

    $74 Million

  • Industries

    Health Tech, Hardware, Biotech, Manufacturing

  • Locations

    Grenoble

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Supernova Invest, Innovacom

  • Contact

    •••••@diabeloop.fr
    Unlock contact info

ImCheck Therapeutics
ImCheck Therapeutics imchecktherapeutics.com
56

ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.

  • Latest Funding

    $100 Million

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma

  • Locations

    Marseille

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Eurazeo, Earlybird Venture Capital, Gimv, Andera Partners

  • Contact

    •••••@imchecktherapeutics.com
    Unlock contact info

BrightHeart
BrightHeart brightheart.fr
54

AI to detect congenital heart defects in fetuses.

  • Latest Funding

    $2.1 Million · Seed

  • Industries

    AI, Biotech

  • Locations

    Paris

  • Employees

    1 to 10

  • Investors

    Sofinnova Partners

  • Contact

    •••••@brightheart.fr
    Unlock contact info

Core Biogenesis
Core Biogenesis corebiogenesis.com
54

Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.

  • Latest Funding

    $11 Million · Series A

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma, Manufacturing

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Entrepreneur First, Thia Ventures, XAnge, Plug and Play Spain

  • Contact

    •••••@corebiogenesis.com
    Unlock contact info

FairCraft
FairCraft faircraft.bio
54

Faircraft is leveraging advanced synthetic biology and material science techniques to develop a lab-grown alternative to animal leather.

  • Latest Funding

    $4.7 Million

  • Industries

    Climate Tech & Green Tech, Fashion, Biotech, Manufacturing

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Kindred Capital, Entrepreneur First

  • Contact

    •••••@faircraft.bio
    Unlock contact info

Inato
Inato inato.com
54

AI-powered data collecting tool for clinical trials.

  • Latest Funding

    $20 Million · Series A

  • Industries

    Health Tech, AI, Biotech, Machine Learning, Pharma

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B, SAAS

  • Investors

    Kima Ventures, Cathay Innovation, Serena, Fly Ventures

  • Contact

    •••••@inato.com
    Unlock contact info

Bon Vivant
Bon Vivant bonvivant-food.com
51

Animal-free dairy protein.

  • Latest Funding

    $16 Million · Series A

  • Industries

    Biotech

  • Locations

    Lyon

  • Employees

    11 to 50

  • Business Model

    B2C

  • Investors

    Kima Ventures, Sofinnova Partners, Founders Future, CapTech, Sparkfood, Picus Capital

  • Contact

    •••••@bonvivant-food.com
    Unlock contact info

Netris Pharma
Netris Pharma netrispharma.com
51

Developer of therapeutic molecules to treat cancer.

  • Latest Funding

    $8.2 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    Lyon

  • Employees

    1 to 10

  • Investors

    EIC Accelerator

  • Contact

    •••••@netrispharma.com
    Unlock contact info

Red Horticulture
Red Horticulture horticulture.red
51

RED Horticulture specializes in horticulture LED lighting systems, photobiology research, and indoor and greenhouse lighting.

  • Latest Funding

    $19 Million · Series A

  • Industries

    Climate Tech & Green Tech, Agritech, Biotech, Energy & Nuclear, Manufacturing

  • Locations

    Lyon

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    European Circular Bioeconomy Fund (ECBF), Unigrains, Demeter Partners

  • Contact

    •••••@horticulture.red
    Unlock contact info

Sensorion
Sensorion sensorion.com
51

Therapeutic treatment for hearing loss disorders.

  • Latest Funding

    $38 Million · Series B

  • Industries

    Health Tech, Biotech

  • Locations

    Montpellier

  • Employees

    11 to 50

  • Business Model

    B2C

  • Investors

    Sofinnova Partners, Invus

  • Contact

    •••••@sensorion.com
    Unlock contact info

WhiteLab Genomics
WhiteLab Genomics whitelabgx.com
50

WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.

  • Latest Funding

    $10 Million · Seed

  • Industries

    Health Tech, Biotech, Genetics, Business Intelligence

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B, SAAS

  • Investors

    Y Combinator

  • Contact

    •••••@whitelabgx.com
    Unlock contact info

Seafood Reboot
Seafood Reboot seafood-reboot.com
50

PLANT-BASED MARINE SUBSTITUTES WITH ALGAE INGREDIENTS. FOR NATURAL, HEALTHY, SUSTAINABLE FOOD

  • Latest Funding

    $3.4 Million · Pre Seed

  • Industries

    Agritech, Foodtech, Biotech, Manufacturing

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2B, B2C

  • Investors

    Founders Future, Demeter Partners

  • Contact

    •••••@seafood-reboot.com
    Unlock contact info

Alira Health
Alira Health alirahealth.com
50

International advisory firm for healthcare sector.

  • Latest Funding

    $58 Million · Series C

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    101 to 250

  • Contact

    •••••@alirahealth.com
    Unlock contact info

Honing Biosciences
Honing Biosciences honing-biosciences.com
50

Bio-therapeutics company that develops and improves cell-based therapies in particular of cancer and other chronic diseases

  • Latest Funding

    $2.3 Million · Pre Seed

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Elaia

  • Contact

    •••••@honing-biosciences.com
    Unlock contact info

InnovaFeed
InnovaFeed innovafeed.com
50

InnovaFeed is a biotech company producing insect-based protein for the feed industry.

  • Latest Funding

    $250 Million · Series D

  • Industries

    Biotech, Deep Tech

  • Locations

    Paris

  • Employees

    101 to 250

  • Contact

    •••••@innovafeed.com
    Unlock contact info

Amatera
Amatera amatera.bio
50

Non-GMO breeding platform.

  • Latest Funding

    $1.5 Million · Pre Seed

  • Industries

    Agritech, Biotech

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    PINC, Joyance Partners, Agfunder, Exceptional Ventures

  • Contact

    •••••@amatera.bio
    Unlock contact info

46

Topical treatments for complex pain.

  • Latest Funding

    $21 Million · Series B

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    1 to 10

  • Contact

    •••••@algotx.com
    Unlock contact info

TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.

  • Latest Funding

    $75 Million

  • Industries

    Health Tech, Biotech, Pharma, Manufacturing

  • Locations

    Bordeaux

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    XAnge

  • Contact

    •••••@treefrog.fr
    Unlock contact info

Depixus
Depixus depixus.com
43

Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.

  • Latest Funding

    $35 Million · Series A

  • Industries

    Health Tech, Biotech, Manufacturing, Genetics

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B

  • Contact

    •••••@depixus.com
    Unlock contact info

DeepLife
DeepLife trydeeplife.org
43

DeepLife uses deep learning on multi-omics data to model cells and efficiently engineer their behavior.

  • Latest Funding

    $6 Million · Series A

  • Industries

    Health Tech, AI, Biotech, Machine Learning

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Kima Ventures, Entrepreneur First

  • Contact

    •••••@trydeeplife.org
    Unlock contact info

Neoplants
Neoplants neoplants.co
43

Houseplants developer to remove harmful air pollutants.

  • Latest Funding

    $20 Million · Seed

  • Industries

    Agritech, Biotech

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2C

  • Investors

    Heartcore, True Ventures, Entrepreneur First

  • Contact

    •••••@neoplants.co
    Unlock contact info

EG 427
EG 427 eg427.com
40

Developing pinpoint gene therapy.

  • Latest Funding

    $5.6 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2C

  • Contact

    •••••@eg427.com
    Unlock contact info

InSpek
InSpek inspek-solutions.com
39

InSpek develops a biological and chemical monitoring systems using integrated photonics.

  • Latest Funding

    $570 Thousand · Pre Seed

  • Industries

    Biotech, Data and Analytics, Robotics, Navigation and Mapping, Manufacturing, Business Intelligence

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Quantonation

  • Contact

    •••••@inspek-solutions.com
    Unlock contact info

37

SeqOne is a next generation genomic analysis for next generation healthcare.

  • Latest Funding

    $23 Million · Series A

  • Industries

    Health Tech, Biotech, Data and Analytics, Business Intelligence

  • Locations

    Montpellier

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Elaia

  • Contact

    •••••@seqone.com
    Unlock contact info

EverImmune
EverImmune everimmune.com
37

EverImmune provides therapeutic tools related to cancer.

  • Latest Funding

    $5.7 Million · Series A

  • Industries

    Health Tech, Biotech, Manufacturing

  • Locations

    Paris

  • Employees

    1 to 10

  • Business Model

    B2B

  • Contact

    •••••@everimmune.com
    Unlock contact info

Polaris
Polaris polaris.fr
37

Polaris is a leader in the Foodtech sector producing high-quality Omega3 oils, rich in EPA and DHA, from fish historically, and microalgae.

  • Latest Funding

    $5.5 Million · Seed

  • Industries

    Health Tech, Foodtech, Biotech, Manufacturing

  • Locations

    Quimper

  • Employees

    11 to 50

  • Business Model

    B2B, B2C

  • Investors

    Seventure Partners

  • Contact

    •••••@polaris.fr
    Unlock contact info

Microphyt
Microphyt microphyt.eu
37

Microphyt researches, develops, produces, and markets natural algae-based products that contribute to weight loss and to brain health.

  • Latest Funding

    $16 Million

  • Industries

    Health Tech, Agritech, Foodtech, Biotech, Fitness, Energy & Nuclear

  • Locations

    Montpellier

  • Employees

    11 to 50

  • Investors

    Bpifrance, Sofinnova Partners, Supernova Invest

  • Contact

    •••••@microphyt.eu
    Unlock contact info

Cell-Easy
Cell-Easy cell-easy.com
37

Cell-Easy is a CDMO that specializes in preclinical and clinical drug development.

  • Latest Funding

    $8.5 Million

  • Industries

    Health Tech, Biotech, Manufacturing

  • Locations

    Toulouse

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    M Capital Partners

  • Contact

    •••••@cell-easy.com
    Unlock contact info

Damae Medical
Damae Medical damae-medical.com
37

DAMAE Medical develops an innovative imaging process for quick and non-invasive skin cancer detection.

  • Latest Funding

    $5.7 Million · Series A

  • Industries

    Health Tech, Hardware, Biotech, Business Intelligence

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B, SAAS

  • Contact

    •••••@damae-medical.com
    Unlock contact info

Healshape
Healshape healshape.com
37

Healshape is a 3D bioprinting regenerative medecine company.

  • Latest Funding

    $6.3 Million

  • Industries

    Health Tech, Biotech, Manufacturing

  • Locations

    Lyon

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Demeter Partners

  • Contact

    •••••@healshape.com
    Unlock contact info

37

Mablink Bioscience is a biotechnology company.

  • Latest Funding

    $30 Million · Series A

  • Industries

    Health Tech, Biotech, Pharma, Manufacturing

  • Locations

    Lyon

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Elaia, Sofinnova Partners

  • Contact

    •••••@mablink.com
    Unlock contact info

PDC*line pharma
PDC*line pharma pdc-line-pharma.com
35

Personalised therapeutic vaccine developer for colorectal cancer.

  • Latest Funding

    $8.7 Million · Series B

  • Industries

    Health Tech, Biotech

  • Locations

    Grenoble

  • Employees

    1 to 10

  • Business Model

    B2C

  • Contact

    •••••@pdc-line-pharma.com
    Unlock contact info

BforCure
BforCure bforcure.com
34

BforCure is a biotech engaged in the manufacture of high speed biosensing solutions such as CHRONOS PCR.

  • Latest Funding

    $5.5 Million

  • Industries

    Health Tech, Biotech, Manufacturing

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B

  • Contact

    •••••@bforcure.com
    Unlock contact info

34

Corlieve Therapeutics is a biotechnology company.

  • Industries

    Health Tech, Biotech

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Pureos Bioventures

  • Contact

    •••••@corlieve.com
    Unlock contact info

DiogenX
DiogenX diogenx.com
32

Regenerative diabetes treatment.

  • Latest Funding

    $30 Million · Series A

  • Industries

    Biotech, Deep Tech

  • Locations

    Marseille

  • Employees

    1 to 10

  • Business Model

    B2C

  • Contact

    •••••@diogenx.com
    Unlock contact info

Hemerion
Hemerion hemerion.com
31

Treatment for brain cancer.

  • Latest Funding

    $2.2 Million · Seed

  • Industries

    Biotech

  • Locations

    Marseille

  • Employees

    11 to 50

  • Investors

    Bpifrance

  • Contact

    •••••@hemerion.com
    Unlock contact info

Qynapse
Qynapse qynapse.com
31

Qynapse offers peace of mind by combining MRI scans and AI to produce rapid, actionable insights into central nervous system (CNS) disorders

  • Latest Funding

    $2.8 Million · Seed

  • Industries

    Health Tech, AI, Biotech, Deep Tech, Machine Learning, Data and Analytics

  • Locations

    Paris

  • Employees

    11 to 50

  • Business Model

    B2B, SAAS

  • Contact

    •••••@qynapse.com
    Unlock contact info